Bispecific trigger molecules recognizing lymphocyte antigen...

Details Bispecific trigger molecules recognizing lymphocyte antigen... Bispecific trigger molecules recognizing lymphocyte antigen...

C - Chemistry, Metallurgy

07

K

C07K 16/46 (2006.01) A61K 35/28 (2006.01) A61K 39/395 (2006.01) C07K 16/28 (2006.01) C07K 16/30 (2006.01) C12P 21/08 (2006.01) A61K 38/00 (2006.01) C12N 5/08 (2006.01)

Patent

CA 2129183

The present invention relates to novel and highly effective bispecific antibody fragments which recognize lymphocyte CD2 antigen and any variable tumor antigen. Moreover, the invention relates to two new monoclonal antibodies termed AICD2.M1 and AICD2.M2. A combination of these antibodies, whereby at least one of them is a bispecfic antibody fragment, can be used successfully in tumor therapy and diagnostics.

Affiliated with

Also associated with

Rating

Bispecific trigger molecules recognizing lymphocyte antigen... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bispecific trigger molecules recognizing lymphocyte antigen..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bispecific trigger molecules recognizing lymphocyte antigen... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1687520